AI Article Synopsis

  • * The study involved 2,962 patients in Japan, using upper gastrointestinal endoscopy to assess various conditions related to GERD and to analyze the correlation of symptoms using the FSSG and GSRS scoring systems.
  • * Results indicate that FSSG and GSRS scores are effective in diagnosing the severity of reflux esophagitis, with FSSG scores linked to mucosal atrophy and GSRS scores relating to the functionality of the gastroesophageal flap.

Article Abstract

Background: Gastroesophageal Reflux Disease (GERD) is caused by the reflux of gastric contents into the esophagus and has a 13% global prevalence that is increasing. GERD symptoms negatively impact physical, social, and emotional quality of life. The Frequency Scale for the Symptoms of GERD (FSSG) and the Gastrointestinal Symptom Rating Scale (GSRS) determine the efficacy of treatment but may not correlate with endoscopically estimated esophageal mucosal injury severity. We aimed to probe the correlation between FSSG, GSRS, and esophageal injury severity to evaluate whether these scores can predict GERD severity.

Methods: A total of 2962 patients who underwent physical examinations, including upper gastrointestinal endoscopy, at the Kyoto Kuramaguchi Medical Center, Japan, were enrolled in this study. Upper gastrointestinal endoscopy was used to diagnose fundic mucosal atrophy, reflux esophagitis based on the Los Angeles (LA) classification, gastroesophageal flap value function (GEFV) based on Hill's classification, and Barrett's esophagus. Endoscopic diagnoses were examined for correlations with FSSG and GSRS scores.

Results: In reflux esophagitis, FSSG and GSRS scores correlated with LA-B and LA-C endoscopic diagnosis but not with LA-M and LA-A endoscopic findings. Multiple regression analysis results were similar. FSSG scores reflected advanced fundic gland mucosal atrophy, while GSRS scores associated with high grade of GEFV.

Conclusions: This is the first report to examine the correlation between FSSG and GSRS scores and endoscopic findings in a relatively large patient population. Our findings suggest that these scores can diagnose the severity of reflux esophagitis.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365521.2024.2406537DOI Listing

Publication Analysis

Top Keywords

fssg gsrs
16
endoscopic findings
12
reflux esophagitis
12
gsrs scores
12
gastrointestinal symptom
8
symptom rating
8
rating scale
8
frequency scale
8
scale symptoms
8
gastroesophageal reflux
8

Similar Publications

Article Synopsis
  • * The study involved 2,962 patients in Japan, using upper gastrointestinal endoscopy to assess various conditions related to GERD and to analyze the correlation of symptoms using the FSSG and GSRS scoring systems.
  • * Results indicate that FSSG and GSRS scores are effective in diagnosing the severity of reflux esophagitis, with FSSG scores linked to mucosal atrophy and GSRS scores relating to the functionality of the gastroesophageal flap.
View Article and Find Full Text PDF

A randomized, placebo-controlled, double-blind, parallel-group clinical study was conducted to examine the effects of ingesting a heat-killed lactic acid bacterium, No. 1088 (LJ88) on temporal gastroesophageal reflux-related symptoms in healthy volunteers. A total of 120 healthy Japanese volunteers of both sexes, aged between 21 and 63 years, whose Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (FSSG) total score was 8 or greater, but who were not diagnosed with functional dyspepsia according to the Rome IV classification, were enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • Vonoprazan is a potassium competitive acid blocker that's shown to be more effective than proton pump inhibitors (PPIs) in treating erosive gastroesophageal reflux disease (GERD), with this study focusing on its use in maintenance therapy.
  • The study involved 122 patients in a randomized cross-over design comparing vonoprazan and lansoprazole, measuring GERD symptoms through various scales over two 4-week periods.
  • Results indicated better symptom control with vonoprazan, with over 93% of patients achieving symptom relief, suggesting it as a viable alternative to PPIs for continuous GERD treatment.
View Article and Find Full Text PDF

In a preliminary open-label trial by our group, Bifidobacterium bifidum YIT 10347 (YIT10347) relieved gastric symptoms in patients with functional gastrointestinal disorders. Hence, in this study, we investigated the effects of YIT10347 on gastrointestinal symptoms in healthy adults. In this prospective double-blind, randomized, placebo-controlled trial (UMIN000024654), 100 healthy Japanese adults were randomly assigned to a YIT10347 group or placebo group and consumed 100 mL of YIT10347-fermented milk or placebo fermented milk, respectively, every day for 4 wk.

View Article and Find Full Text PDF

The aim of the present study was to evaluate the efficacy of a potassium-competitive acid blocker (P-CAB), vonoprazan, for the maintenance therapy of healed reflux esophagitis (RE). A total of 60 patients were enrolled in this open-label, single-center, prospective study. All patients were diagnosed with RE with a frequency scale for the symptoms of gastroesophageal reflux disease (FSSG) total score ≥8 following treatment with standard proton pump inhibitors (PPIs) for a minimum of 8 weeks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!